<?xml version="1.0" encoding="UTF-8"?>
<p>The effect of heparin, mainly LMW heparin, is reported by Tang et al. (
 <xref rid="B9" ref-type="bibr">9</xref>) showing reduced mortality in cases with coagulopathy treated with heparin compared to patients who had coagulopathy not treated with heparin (40.0 vs. 64, 2%, respectively; 
 <italic>p</italic> = 0.029). Heparin exhibits anti-inflammatory effects by neutralizing DAMPs to protect endothelial cells and reduce pulmonary edema and vascular loss.
</p>
